With over 25 years of expertise in pharmaceuticals, Griffin Bay Advisors brings unmatched insights and C-suite leadership experience from billion-dollar organizations. We’re the trusted partner with relationships across the U.S. healthcare landscape and a track record of leading organizations to double-digit-growth.
Our team of former executives and industry experts understands the stakes of pharma commercialization. We don’t just advise; we bring proven strategies for market success in complex sectors. Let us be the catalyst that drives your commercial strategy forward.
Tim deGavre is the General Manager of Griffin Bay Advisors LLC, a consultancy focused on pharmaceutical commercialization and distribution. He previously spent 15 years at Sandoz in senior global and country leadership roles, including Vice President & Chief Commercial Officer, U.S., where he managed a $1.8B P&L across Retail Generics, Hospital Generics, and Biosimilars.
Earlier, as Country Head & General Manager of Sandoz UK, he delivered three consecutive years of double-digit growth, following leadership roles as UK Specialty Head, Global Brand Director, and Head of Biopharmaceutical Strategy. Tim began his career as an Engagement Manager at McKinsey & Company and a Senior Analyst at Frazier Healthcare Ventures.
He holds an MBA with honors from The Wharton School and graduated cum laude from Princeton University.
From concept to commercialization, ensure a seamless launch that maximizes potential.
We know the stakeholders who can drive commercial success and understand what it takes to commercialize a brand in the US.
Navigate acquisitions and product licensing with data-driven insights.
We integrate insights from payers, providers, and patients to shape development decisions that maximize differentiation and relevance.
